Sutro Biopharma's chart data is dated 2026-10-07. There is no active technical signal. There are 0 published signal records.
Sutro Biopharma last closed at $14.66 (+1.45%) on 2026-10-07. Listed on Nasdaq. Trailing 12 months PER is -1.3×. Its overall grade ranks 251 of 737 stocks in Healthcare.
About this company
Sutro Biopharma last closed at $14.66 (+1.45%) on 2026-10-07. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 251/737
Valuation grade B+
Related stocks
- Astellas PharmaCustomer
후기 파이프라인/공동개발 가능성이 큰 글로벌 제약사
- MerckCustomer
항체·ADC 등 외부 파트너십/라이선스 가능성이 큰 대형 제약사
- AstraZenecaCustomer
항암 신약 공동개발과 라이선스 아웃의 주요 잠재 고객
About Sutro Biopharma
- What technical signals does Sutro Biopharma (STRO) have?
- Sutro Biopharma current technical signals: no active technical signal.
- Is Sutro Biopharma a cup-and-handle pattern?
- No. Sutro Biopharma has no valid Cup signal right now.
- What published figures are available for Sutro Biopharma?
- Market cap: $124.89M. Trailing 12 months PER: -1.3×. Latest quarter PBR: -2.35×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-08 dataset
Turn what you saw on this name into a strategy
Ask Q about Sutro Biopharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.